NCT02111252View on ClinicalTrials.gov

A Phase 1/2 Study of a Intramuscular Injection of TAK-850 in Healthy Adult Subjects

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

55

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions

Influenza

Interventions

DRUG

TAK-850

TAK-850 injection

Trial Locations (1)

Unknown

Sumida-ku

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Takeda

INDUSTRY